literature.cafe

512 readers
13 users here now
(and anyone else, really)

This is a general special interest lemmy instance focusing on lovers of all things pertaining to reading and writing and all of the people that enjoy it as well as fandoms and niches that exist within reading circles. We federate with other instances, with our local communities being focused primarily on the above.

If you want to federate a new community, go to lemmyverse.net and copy a link to a community and paste it into the search bar. Be patient!

Also, consider installing instance assistant to better navigate lemmy and find communities better! Find links to download them here: firefox, chrome, edge

Instance Rules
  1. Keep it cozy. (No -isms, bigotry, gatekeeping, or general disrespect. Just be nice!)
  2. Please, no visual porn. (Smut and discussion of smut is OK as long as it is tagged as NSFW.)
  3. No spam.
  4. Be mindful of other instance rules.
  5. Keep self-promo to a minimum.
  6. Tag AI generated content as such.
  7. Please avoid piracy.
Server Info

Registration is open with human approval, just to make sure there's no bots afoot. Approval should take less than a day (and are sometimes near instant)

Please check your spam folder for an email from noreply@literature.cafe if you are having difficulty finding email confirmation.

Community creation is enabled. When creating new communities please be mindful of the instance focus.

If you have any issues or concerns, please message an admin

Fediseer Guarantees

For those visiting from other instances, we have a community directory to make finding communities easier: !411@literature.cafe

We also have alternative lemmy UIs to use for those who want them.

A familiar UI - old.literature.cafe

Photon - ph.literature.cafe

Tesseract (photon fork with more multimedia focused features) - t.literature.cafe

Donations are greatly appreciated and go entirely to server costs but are not required.

List of Patrons Daily Uptime Ratio Weekly Uptime Ratio Average Response Time

founded 1 year ago
ADMINS
gabe
Arthur
admin
listing: all - local
search
1
2
Barely Contained Rage: An Open Letter to Johnson & Johnson (www.youtube.com)
 
 

https://www.hexbear.net/post/277882

2
2
Barely Contained Rage: An Open Letter to Johnson & Johnson (www.youtube.com)
 
 

Biotechnology and continued investment in biomedical research is an important component of ensuring a healthy human society. And intellectual property continues to stand in the way of that as illustrated by the TB treatment situation.

3
0
Johnson and Johnson hold millions of lives hostage: restricting the distribution of life saving generic drug (www.youtube.com)
 
 

“Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents.”

"Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domain… Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth Tell them on facebook: https://www.facebook.com/jnj/ Tell them on instagram: https://www.instagram.com/jnj/?hl=en And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.

Big thanks to TB expert Dr. Carole Mitnick and MSF’s Christophe Perrin for helping me to understand the complexities of drug patents!"

4
2
Johnson and Johnson attempts to sacrifice millions of lives by restricting life saving tuberculosis drug (www.youtube.com)
 
 

"Multidrug resistant tuberculosis is a growing threat, and bedaquiline is essential to curing it. Generic bedaquiline will drive down the cost of the drug by over 60%, allowing far more communities to access and distribute treatment. Evergreening the patent will cost so many lives over the next four years, which Johnson & Johnson knows. They must drop their efforts to enforce the secondary patents."

"Tell Johnson and Johnson that evergreening their patent on bedaquiline, which will deny millions of people access to live-saving treatment, is a violation of their corporate credo: https://secure.ethicspoint.com/domain... Tell them on twitter: https://twitter.com/JNJNews and https://twitter.com/JNJGlobalHealth Tell them on facebook: https://www.facebook.com/jnj/ Tell them on instagram: https://www.instagram.com/jnj/?hl=en And tell them wherever else you can. Tell your friends. Tell your family. Tell the Internet. This must not be allowed to happen.

Big thanks to TB expert Dr. Carole Mitnick and MSF's Christophe Perrin for helping me to understand the complexities of drug patents!"

view more: next ›